Decision pending on diabetes medications
Should new medicines to treat type 2 diabetes be funded?
Should more than 50,000 people receive funding for the drugs?
Government drug-funding agency Pharmac is expected to decide next week whether it will fund two new medicines to treat type 2 diabetes.
Botany resident Graham King and thousands of other people who suffer from the condition hope the decision will fall in their favour.
King (pictured) pays $100 a month for Dapagliflozin, which is used to treat the condition.
Despite the cost, he said it helps control his diabetes and has cut the amount of insulin he has to take.
He said he doesn't think people should endure what he has had to to get modern medicines, like Dapagliflozin, Empagliflozin and Dulaglutide, to treat the condition.
"I'm just lucky I can afford $100 a month."
Figures released by the Ministry of Health last year showed there were 45,266 people registered in the Counties Manukau area with type 2 diabetes in 2019.
Pharmac chief executive Sarah Fitt said that next week its board will look at funding both Empagliflozin and Dulaglutide for 50,000 New Zealanders with type two diabetes who have a high risk of complications such as heart and kidney disease.
"Clinical experts told us that there is evidence for significant benefit from these two medicines in people with established or at high risk of cardiovascular and/or renal disease," she said.
Lest we forget...
On this ANZAC Day, let's take a moment to remember and honor the brave men and women who have served and continue to serve our country.
Tell us who are you honouring today. Whether it's a story from the battlefield or a memory of a family member who fought in the war, we'd love you to share your stories below.
Poll: Does the building consent process need to change?
We definitely need homes that are fit to live in but there are often frustrations when it comes to getting consent to modify your own home.
Do you think changes need made to the current process for building consent? Share your thoughts below.
Type 'Not For Print' if you wish your comments to be excluded from the Conversations column of your local paper.
-
91.4% Yes
-
8.2% No
-
0.4% Other - I'll share below!
Revamp an open wardrobe
Cut visual clutter and give tired shelves new life with doors and colourful Resene paint.
Loading…
